Skip to main content

SY Rha

First name:
SY
Last name:
Rha
Kim, H., Shim, H., Chung, J., Lee, Y., Hong, Y., Rha, S., … Cho, B. (1969). Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer. https://doi.org/10.1002/cncr.26311 (Original work published)
Lee, S., Kim, J., Jang, H., Park, K., Oh, B., Shin, S., … Rha, S. (2018). Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. Cancer Research and Treatment : Official Journal of Korean Cancer Association. https://doi.org/10.4143/crt.2017.535 (Original work published 2018)
Kim, C., Lee, C., Chon, H., Kim, J., Park, H., Heo, S., … Rha, S. (2017). PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer. Oncotarget, 8(69), 113494-113501. https://doi.org/10.18632/oncotarget.23054 (Original work published 2017)
Jeong, B., Cho, K., Jeong, K., Park, Y., Kim, J., Rha, S., … Lee, H. (2018). Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin. Experimental & Molecular Medicine, 50(1), e435. https://doi.org/10.1038/emm.2017.248 (Original work published 2018)